When a private-equity investor considered acquiring an innovative supplier of reusable temperature-controlled packaging (TCP), they turned to HBG for commercial diligence. The deal team needed to validate market growth, competitive positioning, and regulatory and pharmaceutical-industry risks before proceeding. 

The client sought to replace traditional invasive biopsies with a noninvasive, AI-driven imaging and analytics platform capable of real-time cancer detection. The technology showed strong promise across multiple cancers but faced a crowded diagnostics landscape, complex regulatory pathways, and questions about market entry strategy and investor appeal.

The client built an open-source marketplace connecting healthcare developers, researchers, and organizations to share and deploy data-driven applications. With hundreds of contributors and growing traction among developers, the company needed to convert community enthusiasm into enterprise demand among health systems, life-sciences firms, and payers. Leadership sought a scale-up strategy to attract institutional users and prepare for Series A fundraising.

When COVID-19 shut down workplaces, the client’s mobile vision-testing business evaporated overnight. They successfully repurposed their mobile centers to support pharmaceutical trials but were uncertain whether to build a long-term clinical-trials business once normal operations resumed.

A breakthrough technology promised faster, simpler disease-activity testing but clashed with the firm’s original complex platform. Board, founder, and management were deadlocked over which path to pursue.

The investor signed a letter of intent to acquire a fast-growing contract development and manufacturing organization (CDMO) but lacked sector experience. They needed to validate market attractiveness, customer stickiness, and management strength before closing.

Evolving environmental standards and pandemic-driven vaccine transport created volatility in the temperature-controlled packaging market. The company needed an independent market study to educate buyers and strengthen its sale narrative.

A leading, private equity sponsored temperature controlled packaging company sought assistance in positioning itself for sale. Client engaged HBG to conduct a market study and to present findings to leading bidders.

A company that provided mobile vision centers for office workers switched to supporting clinical trials during the pandemic. With normalcy returning, the company needed help to decide whether to invest in building a clinical trials business for the long term.

A development-stage diagnostics company had developed a new technology to assess disease activity with a simple test. The technology had great potential, but pursuing it would be disruptive for the company.